|
PTGFRN expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.66700003484999E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.94249999991337E-07 |
| Normal-vs-Stage2 |
1.049420E-01 |
| Normal-vs-Stage3 |
6.31979999999865E-05 |
| Normal-vs-Stage4 |
4.44000000000555E-05 |
| Stage1-vs-Stage2 |
5.574000E-02 |
| Stage1-vs-Stage3 |
3.281200E-01 |
| Stage1-vs-Stage4 |
2.785800E-01 |
| Stage2-vs-Stage3 |
2.319900E-02 |
| Stage2-vs-Stage4 |
1.973970E-02 |
| Stage3-vs-Stage4 |
9.751200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.69980000075398E-08 |
| Normal-vs-AfricanAmerican |
1.216300E-02 |
| Normal-vs-Asian |
1.442000E-04 |
| Caucasian-vs-AfricanAmerican |
8.061800E-01 |
| Caucasian-vs-Asian |
3.874600E-01 |
| AfricanAmerican-vs-Asian |
3.610600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.94080004792363E-09 |
| Normal-vs-Female |
4.037600E-04 |
| Male-vs-Female |
1.488040E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.419300E-03 |
| Normal-vs-Age(41-60Yrs) |
3.14190000016978E-07 |
| Normal-vs-Age(61-80Yrs) |
4.77290000000519E-06 |
| Normal-vs-Age(81-100Yrs) |
3.892400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.773700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.532400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.836200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.235600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.149200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.231600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.252400E-01 |
| Normal-vs-Grade 2 |
1.88123999999013E-05 |
| Normal-vs-Grade 3 |
2.86490000001027E-06 |
| Normal-vs-Grade 4 |
1.66234999999793E-05 |
| Grade 1-vs-Grade 2 |
7.844000E-01 |
| Grade 1-vs-Grade 3 |
6.248200E-01 |
| Grade 1-vs-Grade 4 |
2.822400E-01 |
| Grade 2-vs-Grade 3 |
4.247400E-01 |
| Grade 2-vs-Grade 4 |
4.162400E-02 |
| Grade 3-vs-Grade 4 |
2.170000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.362000E-01 |
| Normal-vs-ccB subtype |
1.45439216225896E-14 |
| ccA subtype-vs-ccB subtype |
1.74438241629105E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.55200000001776E-06 |
| Normal-vs-N1 |
1.071960E-02 |
| N0-vs-N1 |
1.686030E-01 |
|
|
